Moreover, one might speculate as to whether the cytoprotective effects of APC may be especially effective to counteract thrombotic complications in COVID-19, particularly as EPCR-dependent PAR signaling also induces anti-inflammatory effects [11]. This evidence concerns the gene PROCR and COVID-19.